Vitiligo overview: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''Vitiligo''' ([[International Phonetic Alphabet|IPA]] {{IPA|/ˌvɪtəˈlaɪgo/}}) or '''leukoderma''' is a [[Chronic (medicine)|chronic skin condition]] that causes loss of [[Biological pigment|pigment]], resulting in irregular pale patches of [[skin]]. The precise [[etiology|cause]] of vitiligo is complex and not fully understood. There is some evidence suggesting it is caused by a combination of [[Autoimmunity|auto-immune]], [[Genetics|genetic]], and environmental factors. The population incidence in the United States is considered to be between 1% and 2%. It is considered a rare condition/rare disease that affects only 1 in 2,000 people. | |||
According to Diseases Database: | |||
"A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a [[quiescent]] state is reached." | |||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 13:43, 25 June 2014
|
Vitiligo Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vitiligo overview On the Web |
|
American Roentgen Ray Society Images of Vitiligo overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Vitiligo (IPA Template:IPA) or leukoderma is a chronic skin condition that causes loss of pigment, resulting in irregular pale patches of skin. The precise cause of vitiligo is complex and not fully understood. There is some evidence suggesting it is caused by a combination of auto-immune, genetic, and environmental factors. The population incidence in the United States is considered to be between 1% and 2%. It is considered a rare condition/rare disease that affects only 1 in 2,000 people.
According to Diseases Database: "A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached."
Historical Perspective
Pathophysiology
Differentiating Vitiligo from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
Treatment
Medical Therapy
Primary Prevention
Support organizations
Support groups and organizations are available to help people learn more about vitiligo, understand treatment options, and find support from other people with vitiligo.
Vitiligo Support International is the largest vitiligo organization in the world. The nonprofit organization provides free access to online message boards, chat rooms, frequently asked questions, information and articles, as well as a patient-referred doctor search. The group advocates on behalf of patients, conducts patient conferences and has local support groups.
The National Vitiligo Foundation (NVF) is a 501(c)(3) nonprofit organization that provides access to online resources, physician listings, frequently asked questions (etc); funds research through grants and sponsors local support groups and workshop style conferences.
The American Vitiligo Research Foundation Inc. (AVRF) is a non-profit, tax-exempt charity that aims to increase public awareness about vitiligo and to help those affected by vitiligo, focusing specifically on children and their families. It supports finding a cure through alternatives to animal testing.
VITFriends,LLC is a support group in the North East USA. Formed in 2004, VITFriends is still growing and touching the world. We are a web-community offering words of encouragement and sharing hope to individuals dealing with Vitiligo. The goals is to bring public awareness about this condition as we share HOPE.[2]